Overview
VTI Life Sciences provides validation and compliance services across the pharmaceutical and biotech sectors. They offer a full range of services including computer validation, cleaning validation, process validation, clean room certification, temperature mapping, and qualification of processes, equipment, and facilities. Their work involves conducting and documenting tests, audits, and qualifications to show a facility and its systems meet regulatory standards and quality requirements. The company differentiates itself through its ISO 9001:2000 certification, a commitment to quality, personalized support, and a network of offices in San Diego, San Francisco, Boston, and China that enable broad client coverage. The overall goal is to help clients ensure their operations and facilities comply with industry regulations and operate reliably and safely.
Work here?Claim your company
Simplify's take
What believers are saying
- VTI posted 2026 content on AI, CSA, and PIC/S PI 006-4, showing relevance.
- Its October 2026 pandemic-risk and validation commentary supports lead generation with regulated buyers.
- The ValGenesis alliance expands access to enterprise validation workflows across pharma and medtech accounts.
What critics are saying
- No visible 2026 funding, acquisition, or scaling announcement signals limited growth transparency.
- Services and training revenue face commoditization from ValGenesis, Thermo Fisher, and in-house QA teams.
- If pharmaceutical customers standardize on internal validation platforms, VTI’s consulting moat erodes quickly.
What makes VTI Life Sciences unique
- VTI Life Sciences combines CQV services with automation and validation expertise.
- Its 2023 ValGenesis partnership gives clients governed software plus services integration.
- Dr. David Vincent publishes regulatory thought leadership on CSA, PIC/S, and AI.
Help us improve and share your feedback! Did you find this helpful?